Inspection Record

Prestilux Inc. — Health Canada Inspection Findings

Health CanadaInspected 2026-05-14 6 findingsLaboratory and QC controlsEquipment and facilityOther quality systemComplaint and recall handlingRegulatory reporting and change control

View the regulator's official source The source document is always the basis for judgement.

Findings

1Laboratory and QC controls

The validation and/or the documentation of test methods was inadequate.

2Equipment and facility

The maintenance of personnel records was inadequate.

3Other quality system

The handling of standard operating procedures for good manufacturing practices was inadequate.

4Complaint and recall handling

The quality control department's handling of complaints and/or information received about drug quality was inadequate.

5Other quality system

The electronic system was not validated for its intended use. The controls were inadequate for creating, modifying, reviewing, storing, and/or retrieving records. The controls put in place for electronic signatures were inadequate.

6Regulatory reporting and change control

The change control system was inadequate for ensuring changes are properly documented, evaluated, and/or approved.

About this record

Extracted automatically from the document of the Health Canada inspection on 2026-05-14. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Prestilux Inc. company profile — full history Health Canada documents, 2026 Go to Findings search